Today I am joined by Dr. Anand Shah, a practicing physician and policy maker who has worn multiple hats at the highest levels of our federal health agencies. Most recently, Dr. Shah served as Deputy Commissioner for Medical and Scientific Affairs for the Food and Drug Administration, where he developed and led high-priority FDA policy initiatives. He also served at the Centers for Medicare & Medicaid Services, both as senior medical advisor as well as the Chief Medical Officer for CMMI —the Center for Medicare & Medicaid Innovation. He practices as a radiation oncologist specializing in the early detection & treatment of prostate cancer, and he is currently an Operating Advisor to the global private investment firm Clayton, Dubilier & Rice, and serves as a director for a number of healthcare companies.
In our conversation, we dive into the innerworkings of federal health agencies in the midst of a pandemic, we touch on issues like the threat of antimicrobial resistance, and increasing access to breakthrough medical devices. You'll want to hear Dr. Shah's experience in bringing new technologies to market, redesigning health care delivery with economic incentives, and expanding competition and consumer choice. All that and much more …
To learn more from Dr. Shah, follow him at:
A Second Opinion with Senator Bill Frist, M.D.